Can Eli Lilly become a trillion-dollar pharma giant?

Eli Lilly is betting on weight-loss drugs like Mounjaro, but can it overcome production challenges to become the first trillion-dollar pharmaceutical company?

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here